App-Quantinova.ai

THREE-YEAR CLINICAL RESULTS OF PATIENTS RANDOMIZED TO 3 OR 12 MONTHS OF DUAL ANTIPLATELET AFTER ENDEAVOR ZOTAROLIMUS-ELUTING STENT IMPLANTATION IN OPTIMIZE

Fausto Feresa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

THE COMPARATIVE SAFETY OF BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS ON DIALYSIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM

Devraj Sukul - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

IMPACT OF PRIOR CEREBROVASCULAR EVENTS ON ISCHEMIC AND BLEEDING OUTCOMES WITH CANGRELOR IN PERCUTANEOUS CORONARY INTERVENTION

Neal Narain Sawlani - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

BIVALIRUDIN WITH PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS COMPARED TO HEPARIN WITH PLANNED OR PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: NETWORK META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

Tarpan R. Patel - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

DUAL ANTIPLATELET THERAPY BEYOND ONE YEAR FOLLOWING CORONARY STENTING IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A DUAL ANTIPLATELET THERAPY STUDY ANALYSIS

Laura Mauria - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

EFFICACY AND SAFETY OF LOW TO MEDIUM-DOSE VERSUS HIGH-DOSE ASPIRIN AFTER PERCUTANEOUS CORONARY INTERVENTION: EVIDENCE BEYOND THE CURRENT-OASIS 7 TRIAL

Chirag Bavishi - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

COST IMPLICATIONS OF PROCEDURAL THROMBOTIC COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CHAMPION PHOENIX ECONOMICS STUDY

Hector Tamez - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OPTIMAL P2Y12 INHIBITOR IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS

Asim Rafiquea - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bivalirudin

INITIAL COMMERCIAL EXPERIENCE WITH ORBITAL ATHERECTOMY IN CALCIFIED CORONARY ARTERY DISEASE

Evan Shlofmitz - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

PREDICTORS OF DEFINITE OR PROBABLE STENT THROMBOSIS OCCURRING AFTER 1 YEAR IN A LARGE COHORT OF PATIENTS TREATED WITH OLD AND NEW GENERATION DRUG-ELUTING STENTS IN DAILY CLINICAL PRACTICE

Ricardo Costa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

RANDOMIZED TRIAL TO EVALUATE SAFETY AND FEASIBILITY OF DAY CARE PERCUTANEOUS CORONARY INTERVENTION

Sajid A.H. Dhakam - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

EFFICACY AND SAFETY OF FIRST GENERATION VERSUS NEWER GENERATION DRUG-ELUTING STENTS IN PATIENTS WITH DIABETES: A DIRECT COMPARISON META-ANALYSIS OF 8,438 PATIENTS FROM RANDOMIZED TRIALS

Chirag Bavishi - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

RELATIONSHIP BETWEEN VESSEL SIZE, PLATELET REACTIVITY, AND STENT THROMBOSIS AFTER DRUG-ELUTING STENT PERCUTANEOUS CORONARY ARTERY INTERVENTION

Bjorn Redforsa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

INTRA-STENT THROMBUS FORMATION FOLLOWING BIOLIMUS A-9 ELUTING STENT IMPLANTATION IN PATIENTS WITH SHORTER AND PROLONGED DUAL ANTI-PLATELET THERAPY: OPTICAL COHERENCE TOMOGRAPHY SUB-STUDY OF NIPPON TRIAL

Koji Kuroda - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

COMPARISON OF OUTCOMES AFTER INTRAVASCULAR ULTRASOUND-GUIDED VERSUS ANGIOGRAPHY-GUIDED DRUG-ELUTING STENT IMPLANTATION IN COMPLEX LESIONS CORONARY INTERVENTIONS: A META-ANALYSIS OF 1522 PATIENTS FROM RANDOMIZED TRIALS

Chirag Bavishi - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS COMPARING SAFETY AND EFFICACY OF BIODEGRADABLE POLYMER-COATED VERSUS NEW-GENERATION DURABLE POLYMER DRUG-ELUTING STENTS UP TO 12 MONTHS

Bertrand Njume Muketea - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

SAFETY AND EFFICACY OF THE ABSORB EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD VERSUS NEW-GENERATION DURABLE POLYMER EVEROLIMUS-ELUTING STENTS: A META-ANALYSIS BASED ON CLINICAL OUTCOME DATA FROM RANDOMIZED COMPARISONS

Bertrand Njume Muketea - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

SAFETY AND EFFICACY OF BIORESORBABLE VASCULAR SCAFFOLDS VERSUS METALLIC EVEROLIMUS-ELUTING STENTS IN CORONARY ARTERY DISEASE: A WEIGHTED META-ANALYSIS OF 6 RANDOMIZED CONTROLLED TRIALS ENROLLING 3,733 PATIENTS

Joelle Elias - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

NEW GENERATION DRUG-ELUTING STENT SUPERIOR TO BENCHMARK XIENCE DRUG-ELUTING STENT

Masato Nakamura - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

SECOND-GENERATION VERSUS FIRST-GENERATION DRUG-ELUTING STENTS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: POOLED ANALYSIS FROM THE RESET AND NEXT TRIALS

Kenji Nakatsuma - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Filters

7277 Abstracts